Research Article | Open Access
Volume 2026 - 1 | Article ID 317 | http://dx.doi.org/10.51521/WJTCM.10.51521.101
Academic Editor: John Bose
Shigao
Lin
Graduate School of Hunan University of Chinese
Medicine, Changsha 410208, Hunan, China.
*Corresponding author: Graduate School of Hunan University of Chinese
Medicine, Changsha 410208, Hunan, China, Email: 864086970@qq.com.
Citation: Shigao Lin (2026) Research Progress of Synaptic Plasticity
in Post-Stroke Spasticity: The CCR5/CREB Axis and Traditional Chinese Medicine
Interventions. World J Tradit Complement Med, 1(1);1-7.
Copyright: ©
2026, Shigao Lin, This is an open-access article distributed under the terms of
the Creative Commons Attribution 4.0 International License, which permits
unrestricted use, distribution and reproduction in any medium, provided the
original author and source are credited.
Abstract:
Post-stroke spasticity (PSS) is one of the most disabling sequelae of stroke, yet its treatment remains largely symptomatic. Botulinum toxin, oral antispastic agents and rehabilitation reduce tone without addressing the circuit-level process that generates it. Over the past decade PSS has been reconceptualised: rather than a passive consequence of corticospinal destruction, it is increasingly understood as the behavioural expression of maladaptive reorganisation, in which loss of corticoreticulospinal inhibition and excessive reticulospinal drive converge on hyperexcitable spinal motoneurons. Synaptic plasticity, both functional and structural, is the cellular substrate of that reorganisation. This review first summarises the forms, molecular effectors and measurement strategies of synaptic plasticity in the post-stroke brain, and then argues that the therapeutic objective in PSS is not to maximise plasticity but to restore excitation–inhibition balance within the corticoreticulospinal system. Particular attention is given to the C-C chemokine receptor 5 (CCR5)/cAMP response element-binding protein (CREB) axis, an emerging brake on use-dependent plasticity that couples neuroinflammation to structural remodelling through ERK1/2, Homer1 and PSD-95. Finally, traditional Chinese medicine (TCM) interventions built on the classical principle that contracture should be attributed to blood deficiency are reviewed alongside the pharmacological strategies discussed above, and the experimental agenda required to test whether restoring CCR5/CREB balance is a viable therapeutic strategy is outlined.
Keywords: Post-stroke spasticity; Synaptic plasticity; CCR5; CREB; Corticoreticulospinal
tract; Excitation–inhibition balance; Traditional Chinese medicine.